Childhood- versus Adult-Onset Polyarteritis Nodosa Results from the French Vasculitis Study Group Registry

Autoimmunity Reviews

Volumn 17, Issue 10, 2018, Pages 984-989

  Iudici, Michele ^a   Quartier, Pierre ^b   Pagnoux, Christian ^c   Merlin, Etienne ^d   Agard, Christian ^e   Aouba, Achille ^f   Roblot, Pascal ^g   Cohen, Pascal ^a   Terrier, Benjamin ^a   Mouthon, Luc ^a   Guillevin, Loïc ^a   Puéchal, Xavier ^a  

^a Université Paris Descartes ^*  (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c MOUNT SINAI HOSPITAL   (Canada)

^d Hôpital d'Estaing   (France)

^e HÔTEL DIEU   (France)

^f CHU CÔTE DE NACRE   (France)

^g POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

Adult onset; Childhood onset; Damage; Polyarteritis nodosa; Relapse; Survival

Indexed keywords

CYCLOPHOSPHAMIDE; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; ADULT ONSET POLYARTERITIS NODOSA; ADULTHOOD; BLADDER CANCER; CASE CONTROL STUDY; CHILD; CHILDHOOD; CHILDHOOD ONSET POLYARTERITIS NODOSA; CONTROLLED STUDY; DATA COLLECTION METHOD; DISEASE ACTIVITY; DISEASE REGISTRY; FEMALE; FOLLOW UP; HEMATOLOGIC DISEASE; HUMAN; INFECTION; KAPLAN MEIER METHOD; LIVER DISEASE; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONONEUROPATHY MULTIPLEX; MYALGIA; ONSET AGE; OUTCOME ASSESSMENT; POLYARTERITIS NODOSA; PURPURA; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; RETROSPECTIVE STUDY; REVIEW; SCHOOL CHILD; SKIN; SKIN DISEASE; SURVIVAL RATE; SYSTEMIC DISEASE; SYSTEMIC VASCULITIS; VASCULAR DISEASE; PATHOPHYSIOLOGY; RECURRENT DISEASE;

ADULT; AGE OF ONSET; CHILD; HUMANS; POLYARTERITIS NODOSA; RECURRENCE;

EID: 85051679640     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2018.08.001     Document Type: Review

References (23)

1. Weiss, P.F., Pediatric vasculitis. Pediatr Clin North Am 59 (2012), 407–423.
2. Ozen, S., Anton, J., Arisoy, N., Bakkaloglu, A., Besbas, N., Brogan, P. et al., Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatr 145 (2004), 517–522.
3. Eleftheriou, D., Dillon, M.J., Tullus, K., Marks, S.D., Pilkington, C.A., Roebuck, D.J. et al., Systemic polyarteritis nodosa in the young: a single-center experience over thirty-two years. Arthritis Rheum 65 (2013), 2476–2485.
4. Falcini, F., La Torre, F., Vittadello, F., Rigante, D., Martini, G., Corona, F. et al., Clinical overview and outcome in a cohort of children with polyarteritis nodosa. Clin Exp Rheumatol 32:Suppl. 82 (2014), S134–S137.
5. Iudici, M., Puéchal, X., Pagnoux, C., Quartier, P., Agard, C., Aouba, A. et al., Childhood-onset systemic necrotizing vasculitides: long-term data from the French Vasculitis Study Group registry. Arthritis Rheumatol 67 (2015), 1959–1965.
6. Erden, A., Batu, E.D., Sönmez, H.E., Sari, A., Armagan, B., Arici, Z.S. et al., Comparing polyarteritis nodosa in children and adults: a single center study. Int J Rheum Dis 20 (2017), 1016–1022.
7. Lightfoot, R.W. Jr., Michel, B.A., Bloch, D.A., Hunder, G.G., Zvaifler, N.J., McShane, D.J. et al., The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 33 (1990), 1088–1093.
8. Ozen, S., Pistorio, A., Iusan, S.M., Bakkaloglu, A., Herlin, T., Brik, R. et al., EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 69 (2010), 798–806.
9. Jennette, J.C., Falk, R.J., Bacon, P.A., Basu, N., Cid, M.C., Ferrario, F. et al., 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65 (2013), 1–11.
10. Ozen, S., The changing face of polyarteritis nodosa and necrotizing vasculitis. Nat Rev Rheumatol 13 (2017), 381–386.
11. Merlin, E., Mouy, R., Pereira, B., Mouthon, L., Bourmaud, A., Piette, J.C. et al., Long-term outcome of children with pediatric-onset cutaneous and visceral polyarteritis nodosa. Joint Bone Spine 82 (2015), 251–257.
12. Mukhtyar, C., Lee, R., Brown, D., Carruthers, D., Dasgupta, B., Dubey, S. et al., Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 68 (2009), 1827–1832.
13. Hellmich, B., Flossmann, O., Gross, W.L., Bacon, P., Cohen-Tervaert, J.W., Guillevin, L. et al., EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 66 (2007), 605–617.
14. Exley, A.R., Bacon, P.A., Luqmani, R.A., Kitas, G.D., Gordon, C., Savage, C.O. et al., Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 40 (1997), 371–380.
15. Maeda, M., Kobayashi, M., Okamoto, S., Fuse, T., Matsuyama, T., Watanabe, N. et al., Clinical observation of 14 cases of childhood polyarteritis nodosa in Japan. Acta Paediatr Jpn 39 (1997), 277–279.
16. Mondal, R., Sarkar, S., Pal, P., Nandi, M., Hazri, A., Sabui, T.K., Childhood polyarteritis nodosa: a prospective multicentre study from eastern India. Indian J Pediatr 81 (2014), 371–374.
17. Kallenberg, C.G., Tadema, H., Vasculitis and infections: contribution to the issue of autoimmunity reviews devoted to “autoimmunity and infection”. Autoimmun Rev 8 (2008), 29–32.
18. Guillevin, L., Infections in vasculitis. Best Pract Res Clin Rheumatol 27 (2013), 19–31.
19. Duffy, C.M., Health outcomes in pediatric rheumatic diseases. Curr Opin Rheumatol 16 (2004), 102–108.
20. Iudici, M., Pagnoux, C., Quartier, P., Büchler, M., Cevallos, R., Cohen, P. et al., Childhood- versus adult-onset ANCA-associated vasculitides: a nested, matched case-control study from the French Vasculitis Study Group Registry. Autoimmun Rev 17 (2018), 108–114.
21. Navon Elkan, P., Pierce, S.B., Segel, R., Walsh, T., Barash, J., Padeh, S. et al., Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med 370 (2014), 921–931.
22. Caorsi, R., Penco, F., Grossi, A., Insalaco, A., Omenetti, A., Alessio, M. et al., ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study. Ann Rheum Dis 76 (2017), 1648–1656.
23. Schepp, J., Proietti, M., Frede, N., Buchta, M., Hübscher, K., Rojas Restrepo, J. et al., Screening of 181 patients with antibody deficiency for deficiency of adenosine deaminase 2 sheds new light on the disease in adulthood. Arthritis Rheumatol 69 (2017), 1689–1700.